BIO Announces Jamie Gregorian to Join as Director, Federal Government Relations

WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) announces that Jamie Gregorian will be joining staff as Director, Federal Government Relations.

"Jamie's experience on the Hill and knowledge of health care issues will be an enormous asset to our staff and the overall biopharmaceutical industry."
"We are thrilled that Jamie will be joining BIO," said Brent Del Monte, Senior Vice President of Federal Government Relations. "Jamie's experience on the Hill and knowledge of health care issues will be an enormous asset to our staff and the overall biopharmaceutical industry."

Gregorian comes to BIO after five years with the American Academy of Orthopaedic Surgeons (AAOS). Jamie was AAOS' Senior Manager, Government Relations and Specialties where he worked on a variety of health-related issues and oversaw all advocacy efforts related to judiciary matters, medical research, defense, appropriations, and subspecialty interests.

Prior to joining AAOS, Jamie was a contract lobbyist, and before that a longtime Democratic political consultant.

Gregorian is a native of Boston, a graduate of James Madison University and George Mason University School of Law, and is licensed to practice law in California. He lives in the District of Columbia with his wife Stephanie and their daughters Lily and Ava.

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling "innovations transforming our world" and the BIO Newsletter is the organization's bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events

BIO CEO & Investor Conference
February 9-10, 2015
New York City, NY

BIO-Europe Spring
March 9-11, 2015
Paris, France

BIO Asia International Conference
March 24-25, 2015
Tokyo, Japan

BioEquity Europe
May 19-20, 2015
Vienna, Austria

BIO International Convention
June 15-18, 2015
Philadelphia, PA

Contacts

Biotechnology Industry Organization
Tracy Cooley, APR
202-312-9274
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech
 

Suggested Articles

Disarm Therapeutics signed on Alvin Shih, M.D., the former Retrophin R&D chief who went on to helm Enzyvant, as its full-time CEO.

Pact Pharma launched a phase 1 trial of a technology designed to attack solid tumors with CAR-T cells tailored to individual patients.

Intec's candidate uses a drug delivery system designed to improve on Merck’s Sinemet but was unable to beat the product in a late-phase test.